It has been shown that decreased m6A mRNA methylation led to down-regulated expression of hepatocyte growth factor (c-met), promoting the drug sensitivity of NSCLC cells in a c-MET-/HGF-dependent manner [12]. This evidence concerns the gene HGF and non-small cell lung carcinoma.